Hospital
University of Maryland ST. Joseph Medical Center, LLC
University of Maryland ST. Joseph Medical Center, LLC was paid $638K by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 99284, emergency room visit (serious) — 40% of everything it billed.
33Billing provider infoUNIVERSITY OF MARYLAND ST. JOSEPH MEDICAL CENTER, LLC
TOWSON, MD 21204
TOWSON, MD 21204
33aNPI1124374079assigned 07/30/2012
33bProvider typeGeneral Acute Care Hospital
28Total paid$638K
24GClaims36,648
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#44 of 69
Median peer was paid$870K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,623 | $56K | |
| 2019 | 5,498 | $69K | |
| 2020 | 5,803 | $97K | |
| 2021 | 5,952 | $112K | |
| 2022 | 5,735 | $100K | |
| 2023 | 4,301 | $125K | |
| 2024incomplete | 2,736 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 40% | 2,809 | 2,602 | $258K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 28% | 1,457 | 1,346 | $178K |
| G0378 | Hospital observation service, per hour | 23% | 387 | 350 | $145K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.5% | 429 | 395 | $23K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.0% | 822 | 647 | $13K |
| 84484 | <1% | 2,231 | 1,742 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,566 | 3,853 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,383 | 1,283 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 522 | 465 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,880 | 4,240 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 438 | 408 | $813.01 |
| 84703 | <1% | 481 | 428 | $503.71 |
46 more codes
| 87631 | <1% | 31 | $406.70 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,816 | $374.48 |
| 85610 | <1% | 1,497 | $374.27 | |
| 83735 | <1% | 2,590 | $350.00 | |
| 83690 | <1% | 449 | $336.95 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 124 | $332.90 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 72 | $314.07 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 187 | $290.18 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 16 | $214.75 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 401 | $187.33 |
| 81001 | <1% | 560 | $171.28 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,113 | $151.30 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 479 | $146.22 |
| 81003 | <1% | 890 | $109.97 | |
| 71045 | Radiologic examination, chest; single view | <1% | 136 | $89.69 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 288 | $86.21 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 14 | $70.93 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 137 | $54.77 |
| 83605 | <1% | 67 | $46.62 | |
| J2704 | Injection, propofol, 10 mg | <1% | 708 | $41.67 |
| 85027 | <1% | 146 | $37.97 | |
| 85730 | <1% | 39 | $34.00 | |
| 86850 | <1% | 414 | $29.31 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 295 | $28.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 398 | $22.25 |
| 85379 | <1% | 32 | $21.20 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 130 | $1.95 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 25 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 824 | $0.00 |
| 86900 | 0% | 410 | $0.00 | |
| 87806 | 0% | 74 | $0.00 | |
| 80061 | Lipid panel | 0% | 35 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 975 | $0.00 |
| 86901 | 0% | 407 | $0.00 | |
| 86592 | 0% | 114 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 15 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 55 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 47 | $0.00 |
| 87340 | 0% | 26 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 49 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 43 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 16 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 30 | $0.00 |
| 88342 | 0% | 23 | $0.00 | |
| 82950 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMYTH, THOMAS (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| University of Maryland ST. Joseph Medical Group, LLC | Towson, MD | $6.22M |
| University of Maryland ST. Joseph Pain Specialists, LLC | Towson, MD | $36K |
| University of Maryland ST. Joseph Medical Group | Towson, MD | $29K |
| University of Maryland ST. Joseph Medical Center, LLC | Towson, MD | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.